Thirty-six steers ( 148 to 500 kg) divided into six equal groups were used in a toxic syndrome study of lasalocid and monensin given as a single oral dose. One group was given a placebo, a second group received monensin (25 mg/kg body weight) and the other four groups received lasalocid at 1, 10, 50 or 100 mg/kg body weight (bw). No toxic signs developed in cattle given placebo or lasalocid at I or 10 mg/kg bw dose. The earliest toxic signs were muscle tremors, tachycardia and rumen atony. After 24 h, the cattle were dehydrated, anoreetic and had diarrhea. Deaths occurred between d 1 and 22.5 in the groups receiving lasalocid at 50 and 100 mg/kg bw and monensin. Altered values in blood leucocytes, erythrocytes, hemoglobin, hematocrit, total protein, albumin, creatinine, urea nitrogen, total bilirubin, creatine kinase, lactic dehydrogenase, calcium, chloride and inorganic phosphate occurred I d after dosing: urine pH and specific gravity also changed I d alter dosing. Maximum changes occurred at d 3. Most of the changes were indicative of dehydration rather than specific organ damage.
Introduction
Lasalocid is a divalent polyether antibiotic produced by Streptomyces lasaliensis (Berger et ai., 1951) . It is classified as a divalent ionophore because of its ability to transport both divalent and monovalent (Westley, 1977) cations across lipid membranes. This ionophoric effect determines the microbial activity of the antibiotic. Lasalocid s and monensin 6, a monovalent ionophore, are used commercially as poultry coccidiostats and cattle feed additives.
Preliminary studies with cattle given a single oral dose of lasalocid produced a toxic syndrome similar to that caused by monensin but required a greater dose (Galitzer et al., 1982 The earliest toxic signs of lasalocid appeared in the first 24 h after dosing. The signs were muscle tremors in the flank, increased heart and respiratory rates, and anorexia. These effects began at doses of 50 mg/kg body weight (bw) and were transient. Higher doses increased the duration of toxic effects. At lower doses (10 to 25 mg/kg bw) the cattle were anorectic for 2 to 3 d and had watery diarrhea from the second day lasting up to 5 d. At these lower doses there were no other effects. Postmortem examinations suggested cardiac insufficiency as the cause of death (S. J. Galitzer, unpublished data). The present study was conducted to determine the acute oral toxicity of lasalocid, the ensuing toxic syndrome in cattle, and its similarity to monensin toxicity. The wide range of tests performed was in accordance with current protocols suggested by the Food and Drug Administration in determining the toxic syndrome of a new drug in the target species.
Materials and Methods
Thirty-six Holstein steers (7 to 12 mo of age) weighing an average of 203 kg each and without prior exposure to either lasalocid or monensin were used. The cattle were housed individually in stanchions and were fed a diet of 50% alfalfa hay (1FN 1-80-063) and 50% sorghum grain (IFN 4-04-378); water and salt were provided ad libitum.
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J. Anita. Sci. 1986 Sci. .62:1308 Sci. -1316 The cattle were divided into six groups (six head/group) to test the six treatments. Lasalocid sodium was administered at 1 mg/kg bw (L-I), 10 mg/kg bw (L-10), 50 mg/kg bw (L-50), and 100 mg/kg bw (L-100). Rice hulls were used as a negative control (P-0) and sodium monensin at 25 mg/kg bw (M-25) was used as a positive control. The antibiotic premixes and placebo were weighed into gelatin capsules and loosely packed for oral administration. The experiment was performed as a blind study, i.e., personnel involved in dosing animals, collecting samples and making observations were not aware of treatments or doses that the animals received.
During the 14-d pre-dose period, each animal was observed daily for clinical signs. On the day of dosing (0 d) each animal was observed at 0, .5, 1, 2, 3, 4, 5 and 6 h post-dosing. The animals then were observed twice daily until death, or until sacrificed on d 32. Feed and water consumption were measured daily from -14 to 31 d. Clinical assessment of muscle tremors, heart rate, respiration, body temperature, body condition, fecal appearance, behavior, and rumen motility was done on d -7, 0, 1, 3, 6, 9, 12, 15, 18, 21, 24, 27 and 30 . Fecal appearance was scored as firm, fluid (loose stool), or diarrhea (watery stool).
Blood was collected via jugular venipuncture using Vacutainer 7 tubes with a serum separation barrier (SST | for serum, or with EDTA as anticoagulant for whole blood. Urine was collected via micturition into a clean container. Samples were collected at the same time as the clinical assessment. Blood hemoglobin, hematocrit, erythrocyte and leucocyte counts were determined with a Coulter Model S Senior s. Blood platelets were counted by manual chamber count with an improved Neubauer ruling hemacytometer and WBC-Platelet Unopettes 9.
An automatic analyzer (Technicon SMA 12/ 60) l~ was used to measure serum urea nitrogen, creatinine, total protein, albumin, alkaline phosphatase, glucose, calcium, sodium, potassium, chloride and inorganic phosphate. Total biliru- Sorbitol dehydrogenase (Sigma Chemical Co., 1980) , lactic dehydrogenase and creatine kinase (Abbott VP | Manual, 1981) were measured by UV-kinetic methods. Cholinesterase was measured using a modified Michel pH electrode method (Michel, 1949) .
Urine was analyzed for pH, glucose, ketones, and blood using Labstixll; specific gravity was measured by refractive index with a hand-held refractometer z2. Samples of concentrated urine were diluted with distilled water and the specific gravity noted. The digits to the right of the decimal were multiplied by the dilution factor for a corrected specific gravity. Urine sediment was stained with Sedi-stain 13 and formed elements determined semi-quantitatively by microscopic examination at 430X power.
Steers were selected randomly from the herd, then assigned to stanchions in the barn. Treatments were assigned randomly to the animals and dosed on a mg/kg body weight basis. Bias was controlled by the randomization of animals, animal location, and animal treatment. The analyses used for the observation (variables) followed the statistical model: Effects in the model were tested for significance. Treatment, time period and(or) treatment x time period means and their standard errors were estimated where appropriate. In addition, analysis of variance of the six treatment groups found no significant difference with respect to weight or age when compared by parametric and nonparametric tests.
Results
Mortality. All animals in groups P-0, L-1 or L-10 survived the experiment. In the L-50 (table 1) . In all cases death was preceded by tachycardia, labored respiration and muscle weakness. Necropsies of animals dying in groups L-50, L-100 and M-25 suggested that death resulted from myocardial damage. The changes were flabby heart, petechial and ecchymotic hemorrhages of the heart, edema and increased fluids in the thoracic and abdominal cavities.
Clinical Signs. There were no differences in body temperature, respiration or behavior. No muscle tremors were observed in animals in the P-0 or L-I group. One animal in L-10 had muscle tremors during the first hour. At no other time were muscle tremors observed in this or any other animal in the group. Muscle tremors were observed in the other three groups during the first 24 h post-dosing. In the L-50 group, muscle tremors were observed in three animals at 3 h post-dosing and in five animals between 4 and 6 h post-dosing. All of the animals in the L-100 group had muscle tremors at some time between 3 and 6 h post-dosing. Four of six animals in the M-25 group had muscle tremors at some time between 3 and 6 h post-dosing. No muscle tremors were observed within the groups beyond 24 h. Seven of 15 animals that died or were sacrificed before the end of the experiment had weakness or incoordination before death; one animal was from the L-50 group, four were from the L-100 group (one had a period of opisthotonus) and two were from the M-25 group.
Heart rate increased significantly in groups L-50, L-100 or M-25 (table 2). The heart rates for the L-50 and M-25 groups were elevated between 3 and 6 h after dosing, and for the L-100 group between 3 and 24 h. The rate approached pre-dose rates by 24 h. There was no significant increase in animals of groups P-0, L-1 and L-10.
Cattle feces were graded as to consistency. Firm feces was considered normal. Figure 1 depicts the fecal index of those animals experiencing other-than-normal feces. In general, fluid stool or diarrhea was observed in the L-10, L-50, L-100 and M-25 animals after 24 h postdosing. The diarrhea in these animals was darkcolored and foul-smelling.
Eight of the 36 cattle showed signs of dehydration, i.e., sunken eyes and non-elastic skin, 24 h after dosing. One L-10 animal was dehydrated from d 1 through 3. Three L-50 animals showed signs of dehydration; one was dehydrated from d 1 through 3 and 5 through 6, the second was dehydrated from d 2 through 4, and the third was dehydrated from d 1 through 3. Two L-100 animals had signs of dehydration. These occurred on d 1 and d 1 through 5, respectively. Two M-25 animals had signs of dehydration. These occurred from d 3 through 5 for one animal and d 1 through 3 and d 8 for the other.
Two of the L-I animals bloated (one on d 3 and the other on d 24). A third animal in the L-1 group was a chronic bloater; bloat was observed on d 9, 20 through 24 and 27 through 30. No other animals in the study showed signs of bloat.
The rumen was palpated exteriorly in the paralumbar fossa area and the response was indicated as strong, weak, or absent. Figure 2 indicates that rumen motility was normal in the L-1 and L-10 groups when compared with the placebo group. Rumen motility was often absent or weak in the L-50, L-100, and M-25 groups the first 72 h after dosing. Water and feed intake changed 24 h after dosing (table 3) . Water intake was increased (but not significantly) during the first 3 d after dosing in the L-1 group. In all other lasalocid and monensin treatments, there was a decrease in water intake for the first 3 d after dosing. There was a decrease in feed intake in all groups from d 1 through 3. There was no significant difference in the feed intake between the P-0 platelets/l~l. The leucocyte count of L-50 animals was greater than that of groups P-0, L-1 and L-10 (P<.05). Groups L-100 and M-25 were greater than group L-50 (P<.05). The erythrocyte count of group L-50 was greater than that of groups P-0 and L-I (P<.05); the count for group L-100 was greater than that of the other groups (P<.05). The hemoglobin level was greater in group L-100 than in the other groups (P<.05). The level in group L-50 was greater than in groups P-0, L-I and L-10 (P<.05). Erythrocyte count, hemoglobin concentrations and hematocrit of group M-25 were between those of L-10 and L-50.
The hematocrit was greater in group L-100 than in other groups (P<.05). The hematocrit of M-25 was greater than that of P-0 (P<.05). Three animals in group L-50 had an increase in hematocrit prior to death. Animal A601 had an increase to 26% at d 9, animal A641 had an increase to 26.7% at d 6 and animal A680 had an increase to 28.8% at d 6.
Serum Chemistry.
There was a trend of increased total protein, albumin, creatinine, urea nitrogen, total bilirubin, creatine kinase and lactic dehydrogenase, suggesting a dose-dependent response. Total protein, urea nitrogen and total bilirubin concentration of group M-25 were between those of groups L-10 and L-50. The albumin and creatinine values of group M-25 were between the values of groups L-1 and L-10. The creatine kinase and lactic dehydrogenase values for group M-25 were between the values of groups L-50 and L-100 (table 5) .
The serum total protein in group L-100 was greater than in group L-10 (P<.05). There was no difference between the other groups (P< .05). The albumin of the L-100 group was greater than that of groups L-10 and M-25 (P< .05). There was no difference between the other bSE shown for all groups with sample size N = 6, except where parentheses indicate SE for lasalocid 100 mg/kg group with N = 5. cd 9 in same row that do not have a common superscript differ (P<.05).
groups (P<.05). The creatinine of group L-100 was greater (P<.05) than that of the other groups. There was no difference between the other groups (P<.05). The urea nitrogen varied between groups. Groups P-0 and L-10 urea nitrogen was less than groups L-50, L-100 and M-25 (P<.05); group L-I urea nitrogen was lower than groups L-50 and L-100. Urea nitrogen of the L-100 group was greater than that of groups L-50 and M-25 (P<.05). The alkaline phosphatase of group L-100 was lower than that of P-0 (P<.05). There was no difference between the other groups (P<.05). The total bilirubin of groups L-50, L-100 and M-25 was greater than that of groups P-0, L-l, and L-10 (P<.05). One L-50 animal (A641) had an increase in total bilirubin to 1.2 mg% prior to death at d 6. There was no difference in the sorbital dehydrogenase levels of any group (P<.05). The serum sorbital dehydrogenase for the treated groups was 9.2 to 14.2 lU/liter. The glucose level in group L-50 was lower than that in P-0 (P<.05). There was no difference between the other groups (P<.05). The creatine kinase of groups L-100 and M-25 was greater than all other groups (P<.05). Two L-50 animals had an increase in creatine kinase prior to death 9 Animal A601 had an increase to 2,881 IU/liter at d 9, A641 had an increase to 795 IU/liter at d 6. The lactic dehydrogenase of group L-100 was greater than that of all other groups (P< .05). One L-50 animal (A601) had an increase in lactic dehydrogenase to 3,282 IU/liter prior to death at d 9. There was no difference in the cholinesterase activity of any group (P<.05). The serum cholinesterase for the treated groups was 73.3 to 106.8% of normal.
Serum Electrolytes 9
There was a trend toward decreased calcium and chloride and increased inorganic phosphate, which suggested a dosedependent response. The calcium and chloride concentration of group M-25 was between those of L-10 and L-50 (table 6) .
The total calcium level of group L-50 was lower than that of groups P-0, L-I and L-10 (P<.05). Group L-100 was lower than groups P-0, L-l, L-10 and M-25 (P<.05). The chloride level of groups L-50, L-100 and M-25 was lower than that of groups P-0, L-1 and L-10 (P<.05). The inorganic phosphate level of group L-100 was greater than that of all other groups (P<,05), There was no difference between the other groups (P<.05). The potassium level of M-25 was lower than all other groups (P<.05). There was no difference between the other groups (P<.05). One L-50 animal (A641) had a decrease in potassium to 2.8 meq/liter prior to death at d 6. There was no difference in the serum sodium of any group (P<.05). The serum sodium for the treated groups was 141.7 to 145.3 meq/liter. Urine Chemistry. The urine pH of groups L-50 and M-25 was lower than that of groups P-0, L-l, L-10 and L-100 (P<.05). Specific gravity of P-0 was lower than groups L-50, L-100 and M-25 (P<.05); group L-I was lower than groups L-100 and M-25 (P<.05). Although not statistically significant, there was a trend of increased specific gravity, which suggested a dose-dependent response. The urine specific gravity for group M-25 was highest of all treated groups (table 7) .
There was no treatment-related pattern or variation from day-to-day post-dosing in the types or numbers of elements in the urine sediment within treatment groups. Glucosuria was present in two of six animals in the L-50 group, three of five animals in the L-100 group and one of six animals in the M-25 group. Animals in the other groups had no glucosuria. Two animals in the L-100 group had a positive occult blood, due to free hemoglobin or myoblobin. Ketones were absent in all animals on d 1.
Discussion
Cattle receiving the recommended lasalocid dose of 1 mg/kg bw showed no physical changes other than an increased water intake 24 h after dosing. At 10 times the recommended dose (10 mg/kg bw), no physical changes were observed except for a decreased water and feed intake the first 3 to 4 d after dosing. Twentyfour hours after dosing, one-half the animals (L-10) had fluid stools. The physical changes in those animals receiving lasalocid at 50 mg/kg bw and 100 mg/kg bw were dose-dependent. The first signs observed as early as 3 h post-dosing were tachycardia and muscular tremors. The heart rate remained elevated through 24 h and stabilized by 72 h. Muscle tremors were observed only in the first 24 h post-dosing. There was a decrease in rumen motility 1 to 6 h postdosing. There was a decrease in water and feed intake within the first 24 h. The affected ani- Lasalocid was lethal at 50 and 100 mg/kg bw. Deaths occurred between 2 and 22.5 d after the 50 mg/kg bw dose. At 100 mg/kg bs, toxicity was more acute with death occurring with 1 to 2 d of dosing. The dose selected for monensin (25 mg/kg bw) was in the LDso range of 21.9 to 35.8 mg/kg bw (Eianco Products Co., 1978) . Deaths from monensin occurred between 2.5 and 8.5 d after dosing. Van Vieet et al. (1983) produced toxic signs of anorexia, diarrhea and lethargy in cattle after 1 d of dosing with 25 or 40 mg monensin/kg bw. Therefore, lasalocid appears to be less toxic to cattle than monensin.
Dehydration caused by decreased water intake, coupled to loss via feces, was evidenced by the increase in hematocrit in the most severely affected animals, i.e., those in groups L-100 and M-25. Increased urine specific gravity was an indication of the limited water intake. The detection of glucosuria and normal serum glucose suggested that the ionophores decreased glucose reabsorption in the kidneys. Increased serum urea nitrogen and creatinine indicated decreased glomerular filtration rate, which may have been due to dehydration.
The increases in total protein, albumin and total bilirubin were probably caused by hemoconcentration. There was no evidence of hepatocellular damage as evidenced by normal sorbitol dehydrogenase concentration. Creatine kinase and lactic dehydrogenase are found primarily in skeletal and cardiac muscle. These enzymes leak into serum following muscle activity or upon cell death. An increase in these serum enzymes does not necessarily indicate muscle necrosis.
Lasalocid or monensin may affect hematology. The leucocytosis that occurred may have been due to treatment stress. Van Vleet et al. (1983) found leucocytosis in monensinpoisoned cattle. The increase in erythrocytes and hemoglobin was likely caused by hemoconcentration.
Lasalocid and monensin are biochemically described as ionophores, meaning they have the ability to transport cations by passive diffusion across cell membranes (Pressman, 1968) . In vitro studies have shown that lasalocid will transport divalent cations, while monensin will transport monovalent cations (Pressman, 1976) . Normal membrane function is upset by the abnormal movement of cations via the ionophore. The modified cation flux affects cell membrane function in vitro by altering the resting plasma membrane potential (Devore and Nastuk, 1975; Lichtshtein et al., 1979) . Membrane alteration may have been responsible for the plasma enzyme increases observed. The modified cation flux may also play a role in the muscle tremors that were observed during the first 24 h of toxicity. Muscle contraction is initiated by an increase of calcium ions surrounding the myofibriis. Calcium flux is mediated by a primary Na+/H +, followed by a Ca § +/Na + exchange (Reed, 1982) . Thus, the ionophore may cause an increase of calcium flux that initiates the muscle tremors.
The blood chemistries of animals dying after d 3 were not consistent within each treatment group. This suggests that the cause of death before 3 d may have been different than that after d 3. Similar results were obtained for those animals dosed with 25 mg monensin/kg bw.
The physical signs and pathophysiology developing from lasalocid exposure support the hypothesis that the toxic syndrome of monensin and lasalocid is similar, both in the present study and other reported species studied. The toxic syndrome that develops from lasalocid or monensin poisoning is similar in all species tested. Horses are most sensitive to the drugs, the oral LDso of monensin is 2 to 3 mg/kg bw, while the LDso of lasalocid is 21.5 mg/kg bw (Matsuoka, 1976; Hanson et al., 1981) . Amend (1980) describes the clinicopathologic changes in monensin toxicity in horses as hemoconcentration, hypovolemic shock and progressive muscle damage. Changes to serum chemistries and electrolytes were similar to those found in the present study. The clinical syndrome of lasalocid poisoning in horses included depression, ataxia, paresis, paralysis and anorexia and similar changes to the blood chemistries. Sheep poisoned by monensin develop skeletal and cardiac muscle lesions (Nation et al., 1982; Confer et ai., 1983; Newsholme et ai., 1983) . Anderson et al. (1984) described the clinical signs in sheep as central nervous system depression, anorexia, diarrhea and stiffness. Increases in serum creatine kinase and aspartate amino transferase occurred, but no changes in hemoglobin, packed cell volume, serum osmolarity, protein, fibrinogen, urea nitrogen or albumin were found. Serum electrolytes were not measured.
In general, cattle suffering from lasalocid or monensin toxicity experienced blood and urine changes as a reflection of dehydration during the first 3 d. The animals also experienced glucosuria during this time. No general blood or urine changes, which appeared pathognomonic for ionophore toxicities, occurred after d 3. Animals that seemed to recover from the initial muscular and gastrointestinal syndrome with lasalocid or monensin toxicity died 1 and 2 wk later with little apparent warning. Lesions appearing at necropsy suggest death due to the cardiotoxic effect of the ionophores.
